Bitcoin price today: gains to $120k, near record high on U.S. regulatory cheer
Investing.com - JMP Securities raised its price target on American Healthcare REIT , Inc (NYSE:AHR) to $45.00 from $40.00 on Monday, while maintaining a Market Outperform rating following the company’s second-quarter 2025 results. The stock has demonstrated remarkable strength, delivering a 150% return over the past year and trading near its 52-week high of $41.50. According to InvestingPro analysis, the stock appears to be trading above its Fair Value, with technical indicators suggesting overbought conditions.
American Healthcare REIT reported Core FFO of $0.42 per share for the second quarter, exceeding both JMP’s expectation of $0.39 and the consensus estimate of $0.40 per share. The earnings beat was attributed to higher net operating income (NOI) from the company’s RIDEA assets. The $6.83 billion market cap REIT has shown solid operational performance, with revenue growing 10.05% over the last twelve months. InvestingPro data reveals 12 additional key insights about AHR’s financial health and growth prospects.
The healthcare REIT delivered strong same-store NOI growth, with senior housing operating properties (SHOP) increasing by 23% year-over-year and integrated senior health campuses (ISHC) growing by 18.3% compared to the same period last year.
Based on year-to-date performance, American Healthcare REIT raised its full-year 2025 Core FFO guidance by $0.05 per share at the midpoint, representing a 3.1% increase from previous guidance.
JMP noted that management has been opportunistic with capital raising activities, enabling accretive and deleveraging external growth focused on SHOP/ISHC assets, and believes the company is "uniquely positioned in the REIT world to drive outsized value" through its RIDEA portfolio fundamentals and equity pricing.
In other recent news, American Healthcare REIT reported its financial results for the second quarter of 2025, highlighting a 27% increase in normalized funds from operations (NFFO) per share. The company also raised its full-year 2025 NFFO guidance. These developments reflect a strong performance and positive investor sentiment. Additionally, the company’s stock showed an increase in after-hours trading following the announcement. The earnings call underscored the company’s growth trajectory. No analyst upgrades or downgrades were reported in the recent period. The recent developments indicate a focus on financial growth and operational efficiency.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.